glp 1 heart attack GLP-1 Receptor Agonists in Failure GLP-1 drugs may cut risk

(PubMed) Sridharan K, Sivaramakrishnan G

While direct endometriosis trials are minimal, these anti-inflammatory mechanisms suggest GLP-1s could theoretically support metabolic and immune stability in women with endometriosisthough clinical evidence remains preliminary and requires provider guidance

Dong, Q

Key findings from SURMOUNT-1 include a mean weight loss of 15.0% at the 5mg dose, 19.5% at the 10mg dose, and 20.9% at the 15mg dose over 72 weeks

Severe reactions like hives, swelling, or breathing difficulties require immediate product discontinuation, gentle washing with cool water, and medical attention as needed

H.ShivnaniA.MaiJ.ChinnaiyanP.KrauseR